La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Luyan PharmaLtd Bilan de santé
Santé financière contrôle des critères 5/6
Luyan PharmaLtd has a total shareholder equity of CN¥3.0B and total debt of CN¥4.9B, which brings its debt-to-equity ratio to 162.3%. Its total assets and total liabilities are CN¥12.0B and CN¥9.0B respectively. Luyan PharmaLtd's EBIT is CN¥695.4M making its interest coverage ratio 3.2. It has cash and short-term investments of CN¥458.1M.
Informations clés
162.3%
Ratio d'endettement
CN¥4.94b
Dette
| Ratio de couverture des intérêts | 3.2x |
| Argent liquide | CN¥458.14m |
| Fonds propres | CN¥3.04b |
| Total du passif | CN¥8.98b |
| Total des actifs | CN¥12.02b |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
Analyse de la situation financière
Passif à court terme: 002788's short term assets (CN¥9.5B) exceed its short term liabilities (CN¥8.2B).
Passif à long terme: 002788's short term assets (CN¥9.5B) exceed its long term liabilities (CN¥798.0M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 002788's net debt to equity ratio (147.2%) is considered high.
Réduire la dette: 002788's debt to equity ratio has reduced from 174.2% to 162.3% over the past 5 years.
Couverture de la dette: 002788's debt is well covered by operating cash flow (22.1%).
Couverture des intérêts: 002788's interest payments on its debt are well covered by EBIT (3.2x coverage).